Related Experiment Videos

Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma

J L Rohn1, A S Lauring, M L Linenberger

  • 1Department of Microbiology, University of Washington, Seattle 98195, USA.

Journal of Virology
|November 1, 1996
PubMed

Insights

Researchers discovered novel feline leukemia virus (FeLV) recombinants encoding Notch2 in experimentally infected cats. This suggests a nuclear, activated Notch2 protein contributes to FeLV-induced leukemogenesis.

Area of Science:

  • Virology
  • Oncology
  • Molecular Biology

Background:

  • Feline leukemia virus (FeLV) is associated with neoplastic diseases in cats.
  • Mechanisms include transduction of host proto-oncogenes, but experimental evidence for unrelated gene acquisition was lacking.

Purpose of the Study:

  • To investigate the potential for recombinant FeLV proviruses encoding host genes in experimental infections.
  • To identify novel FeLV recombinants and their role in leukemogenesis.

Main Methods:

  • Isolation and characterization of recombinant FeLV proviruses from thymic lymphoma DNA of cats experimentally infected with FeLV-61E.
  • Analysis of recombinant genome structure, including transduction junctions and gene insertions.
  • Characterization of the viral protein product, including its size, localization, and potential function.

Main Results:

  • Four recombinant FeLV proviruses encoding feline Notch2 sequences were identified in two cats.
  • These recombinants replaced most of the FeLV envelope gene with a Notch2 region containing the ankyrin repeat domain.
  • A novel, truncated 65-70 kD Notch2 protein was produced, targeted to the cell nucleus.

Conclusions:

  • The study provides the first experimental evidence of unrelated host gene acquisition by FeLV.
  • A nuclear, activated Notch2 protein is implicated as a key factor in FeLV-induced leukemogenesis.

Related Concept Videos